BHC (Bausch Health) Rega marang bathi mangsa ngarep

Bausch Health Companies (BHC) collaborates with ophthalmology centers to develop innovative treatments. The global scale of the business relies on a patent model with high margins for the mass production of pharmaceuticals. The holding company is currently restructuring massive debts and spinning off specialized units to stabilize capital flows. The trajectory of the company's future P/E reflects a real-time valuation, where the indicator stands at 1.90.

Rega marang bathi mangsa ngarep: bauschhealth.com (BHC) kanggo 04.07.2022 - 14.11.2026

Rincian analitis lan laporan data perusahaan Bausch Health Corp (BHC)

- kuotasi lan prakiraan analis:

Rega saham Bausch Health|BHC - Konsensus nilai wajar

- indikator valuasi pasar bisnis:

Nilai pasar Bausch Health Companies|BHC - Total Nilai Perusahaan

- data ekuitas miturut neraca:

Aset Bersih saben Siji Saham Bausch Health|BHC - Nilai Buku Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku bauschhealth.com|BHC - Total Aset Bisnis

- data tingkat utang lan likuiditas finansial:

Total Utang marang Modal Bausch Health Companies|BHC - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Bausch Health Companies|BHC - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Bausch Health Companies|BHC - Tanggungan jangka dawa|Utang jangka cendhak perusahaan Bausch Health|Rasio cepet bauschhealth.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

BHC - Bathi resik|Bathi mangsa ngarep Bausch Health Companies|BHC - Pangali P/E|Rega marang bathi mangsa ngarep Valeant Pharmaceuticals|BHC - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Bausch Health Companies|BHC - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Bausch Health|BHC - Bathi saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan bauschhealth.com|BHC - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Bausch Health Companies

- rincian pendapatan lan dodolan emiten:

BHC - Pendapatan dodolan perusahaan|Prakiraan volume dodolan Bausch Health|BHC - Rega marang dodolan|Multiplikator Forward P/S Bausch Health Companies

Ringkesan analitik perusahaan:Bausch Health

Investing in Bausch Health Companies (BHC) requires a rigorous analysis of expected returns, as the company's future P/E multiple aligns current market value with net income forecasts, revealing discrepancies in growth rate valuations. This chart allows for the determination of a fair value range for the asset, given that high debt leverage and patent risks for Bausch Health Companies (BHC) limit capitalization potential.

Analisis pesaing

Pangali Forward P/E LLY|ABBV (AbbVie Inc) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep AstraZeneca AB AZN|Novartis Pharma (NVS) - Rasio prakiraan rega marang bathi|MRK - Rega marang bathi mangsa ngarep|NVO: Rega marang bathi mangsa ngarep|AMGN: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep PFE|SNY (Sanofi Aventis) - Pangali Forward P/E|Bristol-Myers Squibb Co. (BMY) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep GSK plc (GSK)|takeda.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E TEVA (Teva Pharmaceutical Industries Limited)|Pangali forward rega marang bathi Dr. Reddy's Laboratories Limited|Viatris Corp - Pangali Forward P/E|ROIV: Rega marang bathi mangsa ngarep|ZLAB: Pangali Forward P/E|cosmosholdingsinc.com (COSM) - Pangali Forward P/E